Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

New treatments for lupus show promise, but more research is needed, especially for children.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Targeted cancer therapies often cause serious skin problems that need careful management.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Both mouse and rat models are effective for testing alopecia areata treatments.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Substance from human umbilical cord blood cells promotes hair growth.